Painkiller Patents Too Vague To Stand, Fed. Circ. Says
The Patent Trial and Appeal Board rightly rejected claims as unpatentable in two drug patent applications covering painkillers, the Federal Circuit affirmed Tuesday, finding Purdue Pharma's patents lacked written descriptions....To view the full article, register now.
Already a subscriber? Click here to view full article